These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 4926920)

  • 21. [The trial of intravenous L-DOPA in patients with Parkinson's disease].
    Nardini M; Fieschi C; Agnoli A; Arcioli I; Zanette E
    Riv Neurol; 1970; 40(2):75-85. PubMed ID: 5429003
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment with L-dopa in Parkinsonian syndromes].
    De Renzi E; Pieczuro A
    Sist Nerv; 1970; 22(1):1-11. PubMed ID: 5502951
    [No Abstract]   [Full Text] [Related]  

  • 23. [Toulouse-Piéron test in patients with Parkinsonism treated with L-dopa].
    Megna GF; Puca FM; Leggiadro N; Micalizzi V; Pigneri MT
    Acta Neurol (Napoli); 1973; 28(2):213-22. PubMed ID: 4575429
    [No Abstract]   [Full Text] [Related]  

  • 24. [Amantadine and L-Dopa in the treatment of parkinsonian syndromes].
    Kluzer G; Lampo B
    Minerva Med; 1971 Oct; 62(82):4013-4. PubMed ID: 5125067
    [No Abstract]   [Full Text] [Related]  

  • 25. [Current status of therapy of parkinsonism].
    Walton JN
    Recenti Prog Med; 1971 Sep; 51(3):274-88. PubMed ID: 5171957
    [No Abstract]   [Full Text] [Related]  

  • 26. [Amantadine and L-Dopa in the treatment of parkinsonian syndromes and their implications for rehabilitation].
    Raspa EG; Paciaroni E; Saccomanno G
    Minerva Med; 1971 Oct; 62(82):4031-5. PubMed ID: 5125073
    [No Abstract]   [Full Text] [Related]  

  • 27. Parkinsonism.
    Med J Aust; 1970 Apr; 1(15):742-3. PubMed ID: 4317184
    [No Abstract]   [Full Text] [Related]  

  • 28. [Therapy of parkinsonian syndromes with L-dopa. Results and prospects].
    Fazio C
    Sist Nerv; 1970; 22(2):61-6. PubMed ID: 5504558
    [No Abstract]   [Full Text] [Related]  

  • 29. [Longtime study on the effects of L-dopa therapy in parkinsonism].
    Fischer PA; Schneider E; Jacobi P; Maxion H
    Nervenarzt; 1973 Mar; 44(3):128-35. PubMed ID: 4572536
    [No Abstract]   [Full Text] [Related]  

  • 30. [L-dopa therapy in Parkinsonian syndromes].
    Policlinico Prat; 1970 Sep; 77(36):1156-61. PubMed ID: 5495548
    [No Abstract]   [Full Text] [Related]  

  • 31. Current concepts of Parkinsonism.
    Pearce J; Pearce I
    Postgrad Med J; 1971 Dec; 47(554):794-9. PubMed ID: 4945017
    [No Abstract]   [Full Text] [Related]  

  • 32. Anticholinergic withdrawal and benzhexol treatment in Parkinson's disease.
    Horrocks PM; Vicary DJ; Rees JE; Parkes JD; Marsden CD
    J Neurol Neurosurg Psychiatry; 1973 Dec; 36(6):936-41. PubMed ID: 4772727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Neurophysiologic exploration of the parkinsonian syndromes treated with L-dopa. Technic and 1st results].
    Mahoudeau D; Bathien N; Singer B; Bourdarias H; Renou G
    Rev Neurol (Paris); 1970 Dec; 123(6):453-7. PubMed ID: 5513753
    [No Abstract]   [Full Text] [Related]  

  • 34. Quantitative measurements of L-dopa therapy in Parkinson's disease.
    Webster DD
    Neurology; 1970 Apr; 20(4):376-7. PubMed ID: 4935022
    [No Abstract]   [Full Text] [Related]  

  • 35. [L-Dopa-Propranolol association and parkinsonian trembling].
    Kissel P; Tridon P; Masingue M; Andre JM
    Nouv Presse Med; 1972 Jul; 1(29):1943. PubMed ID: 5053603
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of parkinsonian akinesia].
    Travenets IA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1966; 66(5):703-6. PubMed ID: 5998829
    [No Abstract]   [Full Text] [Related]  

  • 37. [Current therapeutic problems of the parkinson syndrome].
    Völler GW; Kapp W
    Med Welt; 1971 Aug; 33():1280-2. PubMed ID: 5566844
    [No Abstract]   [Full Text] [Related]  

  • 38. [Our first observations on Parkinson's disease or parkinsonian syndromes treated with L-dopa].
    Boudouresques J; Khalil R; Vigouroux RA; Gosset A; Daniel F; Dufour H
    Mars Med; 1971; 108(2):85-9. PubMed ID: 5548385
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical considerations on therapy of parkinsonian syndromes with amantadine and L-Dopa].
    Ambrosetto C; Martinelli P
    Minerva Med; 1971 Oct; 62(82):4017-9. PubMed ID: 5125069
    [No Abstract]   [Full Text] [Related]  

  • 40. Orobuccal dyskinesia associated with trihexyphenidyl therapy in a patient with Parkinson's disease.
    Hauser RA; Olanow CW
    Mov Disord; 1993 Oct; 8(4):512-4. PubMed ID: 8232363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.